Peps
What is Desmopressin?
Desmopressin is a hormone analogue used in specific water-balance and related conditions. Its effects depend on the formulation and clinical setting.
Biological role or research focus
Water conservation through vasopressin-related signaling.
Its uses concern specific fluid-balance conditions. Product instructions and fluid precautions require clinical guidance.
Role reference: MedlinePlus · Desmopressin ↗
Names you may encounter
DDAVP
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Vasopressin analogue
- Main research area
- Water conservation
- Evidence featured
- Human randomized trial
- Source check
- October 4, 2026
Source: MedlinePlus · Desmopressin ↗
Molecular structure
Mechanism & research rationale
It replaces aspects of vasopressin signaling, helping the body conserve water and balance salt and fluid. This concerns water handling rather than glucose lowering.
Source: MedlinePlus · Desmopressin ↗
Clinical uses & product context
The oral medication reference covers central diabetes insipidus, certain post-injury or postsurgical symptoms, and bedwetting. The study below concerns a distinct orally disintegrating nocturia formulation. Their instructions are not interchangeable.
Source: MedlinePlus · Desmopressin ↗
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Human randomized trial · 2012
Nocturia formulation study
Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
- Population / model
- 757 adults in the intention-to-treat population, mostly with excessive nighttime urine production.
- Study design
- Four-week placebo-controlled study of an orally disintegrating formulation.
- Main finding
- Nighttime voiding decreased and the first sleep period lengthened. Clinically important low sodium occurred in some treatment groups.
- Limits & context
- Formulation and patient selection matter. This study cannot supply instructions for a different desmopressin product, and fewer bathroom trips must be weighed against hyponatremia risk.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
Desmopressin. ↗
· 2006 · Review
Desmopressin. ↗
· 2023 Jan · Study Guide
Desmopressin and antifibrinolytics. ↗
International anesthesiology clinics · 1990 Fall · Journal Article, Review
Intranasal desmopressin-induced hyponatremia. ↗
Pharmacotherapy · 1996 Jan-Feb · Case Reports, Journal Article, Review
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Key precautions
Retaining too much water can lower blood sodium dangerously. Fluid intake, kidney function, interacting medicines, and sodium monitoring are central clinical considerations.
Source: MedlinePlus · Desmopressin ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
0 matching video records · 0 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
No matching video has been identified in the current snapshot.
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
We have not added a supplier for this profile. Missing products and coded listings are not filled with guesses.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Which indication and formulation does the source describe?
- Does the video make a broader claim than the source supports?
- Its uses concern specific fluid-balance conditions. Product instructions and fluid precautions require clinical guidance.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Is diabetes insipidus the same as diabetes mellitus?
No. The former concerns water regulation; the latter concerns blood-glucose regulation.
Source: MedlinePlus · Desmopressin ↗
Can one formulation’s study determine another product’s use?
No. Product-specific absorption, indication, and precautions must be checked.
References & editorial record
- MedlinePlus · Desmopressin ↗
- Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. ↗
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.